The commonly used drugs in endocrine therapy for breast cancer include estrogen analogs (tamoxifen, toremifene), ER degraders (fulvestrant), and aromatase inhibitors (letrozole, anastrozole, exemestane). Here, ESR1 is linked to breast cancer.